Proteomics of bacterial pathogens: Pseudomonas aeruginosa infections in cystic fibrosis - A case study

Proteomics - Clinical Applications

Volumn 4, Issue 2, 2010, Pages 228-248

  Hare, Nathan J ^a   Cordwell, Stuart J ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Biofilm; Cystic fibrosis infections; Proteomics; Pseudomonas aeruginosa; Quorum sensing

Indexed keywords

ALGINIC ACID; ALKALINE PROTEINASE; AZITHROMYCIN; CALCIUM; CATALASE; CIPROFLOXACIN; ELASTASE; EXOTOXIN; HYDROGEN CYANIDE; MAGNESIUM; PROTEIN KATA; PROTEINASE; PYOCHELIN; PYOCYANINE; PYOVERDINE; RHAMNOLIPID; SIDEROPHORE; SIGMA FACTOR RPOS; SODIUM; STAPHYLOLYSIN; SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE A; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL GENETICS; BACTERIAL GROWTH; BACTERIAL KINETICS; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; CYSTIC FIBROSIS; DISEASE COURSE; HOST PATHOGEN INTERACTION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; MEMBRANE FORMATION; MICROBIAL COMMUNITY; MICROENVIRONMENT; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN PROCESSING; PROTEOMICS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; QUORUM SENSING; REVIEW; STRAIN DIFFERENCE;

ANIMALS; CYSTIC FIBROSIS; HUMANS; LUNG; PROTEOMICS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

BACTERIA (MICROORGANISMS); PROKARYOTA; PSEUDOMONAS AERUGINOSA;

EID: 77951925095     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.200900144     Document Type: Review

References (154)

1. Fleischmann, R.D., Adams, M.D., White, O., Clayton, R.A. et al., Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 1995, 269, 496-512.
2. MacLean, D., Jones, J.D., Studholme, D.J., Application of 'next-generation' sequencing technologies to microbial genetics. Nat. Rev. Microbiol. 2009, 7, 287-296.
3. Tettelin, H., Riley, D., Cattuto, C., Medini, D., Comparative genomics: the bacterial pan-genome. Curr. Opin. Microbiol. 2008, 11, 472-477.
4. Velculescu, V.E., Zhang, L., Zhou, W., Vogelstein, J. et al., Characterization of the yeast transcriptome. Cell 1997, 88, 243-251.
5. Velculescu, V.E., Zhang, L., Vogelstein, B., Kinzler, K.W., Serial analysis of gene expression. Science 1995, 270, 484-487.
6. Nagalakshmi, U., Wang, Z., Waern, K., Shou, C. et al., The transcriptional landscape of the yeast genome defined by RNA sequencing. Science 2008, 320, 1344-1349.
7. Lewis, N.E., Cho, B.K., Knight, E.M., Palsson, B.O., Gene expression profiling and the use of genome-scale in silico models of Escherichia coli for analysis: providing context for content. J. Bacteriol. 2009, 191, 3437-3444.
8. Shendure, J., Ji, H., Next-generation DNA sequencing. Nat. Biotechnol. 2008, 26, 1135-1145.
9. Stover, C.K., Pham, X.Q., Erwin, A.L., Mizoguchi, S.D. et al., Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 2000, 406, 959-964.
10. Lyczak, J.B., Cannon, C.L., Pier, G.B., Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect. 2000, 2, 1051-1060.
11. Lyczak, J.B., Cannon, C.L., Pier, G.B., Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 2002, 15, 194-222.
12. Conway, S.P., Brownlee, K.G., Denton, M., Peckham, D.G., Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis. Am. J. Respir. Med. 2003, 2, 321-332.
13. Ryder, C., Byrd, M., Wozniak, D.J., Role of polysaccharides in Pseudomonas aeruginosa biofilm development. Curr. Opin. Microbiol. 2007, 10, 644-648.
14. Govan, J.R., Deretic, V., Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 1996, 60, 539-574.
15. Armstrong, D., Bell, S., Robinson, M., Bye, P. et al., Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics. J. Clin. Microbiol. 2003, 41, 2266-2267.
16. O'Carroll, M.R., Syrmis, M.W., Wainwright, C.E., Greer, R.M. et al., Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units. Eur. Respir. J. 2004, 24, 101-106.
17. Bradbury, R., Champion, A., Reid, D.W., Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population. Respirology 2008, 13, 886-892.
18. Jones, A.M., Govan, J.R., Doherty, C.J., Dodd, M.E. et al., Spread of amultiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 2001, 358, 557-558.
19. Cheng, K., Smyth, R.L., Govan, J.R., Doherty, C. et al., Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 1996, 348, 639-642.
20. Scott, F.W., Pitt, T.L., Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. J. Med. Microbiol. 2004, 53, 609-615.
21. Pellegrino, F.L., Casali, N., Dos Santos, K.R., Nouer, S.A. et al., Pseudomonas aeruginosa epidemic strain carrying bla(SPM) metallo-beta-lactamase detected in Rio de Janeiro, Brazil. J. Chemother. 2006, 18, 151-156.
22. Jelsbak, L., Johansen, H.K., Frost, A.L., Thogersen, R. et al., Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect. Immun. 2007, 75, 2214-2224.
23. Aebersold, R., Mann, M., Mass spectrometry-based proteomics. Nature 2003, 422, 198-207.
24. Cravatt, B.F., Simon, G.M., Yates, J.R., III, The biological impact of mass-spectrometry-based proteomics. Nature 2007, 450, 991-1000.
25. Gorg, A., Weiss, W., Dunn, M.J., Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004, 4, 3665-3685.
26. Thingholm, T.E., Jensen, O.N., Larsen, M.R., Analytical strategies for phosphoproteomics. Proteomics 2009, 9, 1451-1468.
27. Cordwell, S.J., Nouwens, A.S., Verrills, N.M., Basseal, D.J., Walsh, B.J., Subproteomics based upon protein cellular location and relative solubilities in conjunction with composite two-dimensional electrophoresis gels. Electrophoresis 2000, 21, 1094-1103.
28. Cordwell, S.J., Technologies for bacterial surface proteomics. Curr. Opin. Microbiol. 2006, 9, 320-329.
29. Nouwens, A.S., Cordwell, S.J., Larsen, M.R., Molloy, M.P. et al., Complementing genomics with proteomics: the membrane subproteome of Pseudomonas aeruginosa PAO1. Electrophoresis 2000, 21, 3797-3809.
30. Blonder, J., Goshe, M.B., Xiao, W., Camp, D.G., II et al., Global analysis of the membrane subproteome of Pseudomonas aeruginosa using liquid chromatography-tandem mass spectrometry. J. Proteome Res. 2004, 3, 434-444.
31. Lu, B., McClatchy, D.B., Kim, J.Y., Yates, J.R., III, Strategies for shotgun identification of integral membrane proteins by tandem mass spectrometry. Proteomics 2008, 8, 3947-3955.
32. Peng, X., Xu, C., Ren, H., Lin, X. et al., Proteomic analysis of the sarcosine-insoluble outer membrane fraction of Pseudomonas aeruginosa responding to ampicilin, kanamycin, and tetracycline resistance. J. Proteome Res. 2005, 4, 2257-2265.
33. Imperi, F., Ciccosanti, F., Perdomo, A.B., Tiburzi, F. et al., Analysis of the periplasmic proteome of Pseudomonas aeruginosa, a metabolically versatile opportunistic pathogen. Proteomics 2009, 9, 1901-1915.
34. Visca, P., Imperi, F., Lamont, I.L., Pyoverdine siderophores: from biogenesis to biosignificance. Trends Microbiol. 2007, 15, 22-30.
35. Buckling, A., Harrison, F., Vos, M., Brockhurst, M.A. et al., Siderophore-mediated cooperation and virulence in Pseudomonas aeruginosa. FEMS Microbiol. Ecol. 2007, 62, 135-141.
36. Lau, G.W., Hassett, D.J., Ran, H., Kong, F., The role of pyocyanin in Pseudomonas aeruginosa infection. Trends Mol. Med. 2004, 10, 599-606.
37. Engel, J., Balachandran, P., Role of Pseudomonas aeruginosa type III effectors in disease. Curr. Opin. Microbiol. 2009, 12, 61-66.
38. Shafikhani, S.H., Morales, C., Engel, J., The Pseudomonas aeruginosa type III secreted toxin ExoT is necessary and sufficient to induce apoptosis in epithelial cells. Cell. Microbiol. 2008, 10, 994-1007.
39. Jia, J., Wang, Y., Zhou, L., Jin, S., Expression of Pseudomonas aeruginosa toxin ExoS effectively induces apoptosis in host cells. Infect. Immun. 2006, 74, 6557-6570.
40. Nouwens, A.S., Willcox, M.D.P., Walsh, B.J., Cordwell, S.J., Proteomic comparison of membrane and extracellular proteins from invasive (PAO1) and cytotoxic (6206) strains of Pseudomonas aeruginosa. Proteomics 2002, 2, 1325-1346.
41. Wehmhoner, D., Haussler, S., Tümmler, B., Jansch, L. et al., Inter- and intraclonal diversity of the Pseudomonas aeruginosa proteome manifests within the secretome. J. Bacteriol. 2003, 185, 5807-5814.
42. Upritchard, H.G., Cordwell, S.J., Lamont, I.L., Immunoproteomics to examine cystic fibrosis host interactions with extracellular Pseudomonas aeruginosa proteins. Infect. Immun. 2008, 76, 4624-4632.
43. Sriramulu, D.D., Nimtz, M., Römling, U., Proteome analysis reveals adaptation of Pseudomonas aeruginosa to the cystic fibrosis lung environment. Proteomics 2005, 5, 3712-3721.
44. McLafferty, F.W., Breuker, K., Jin, M., Han, X. et al., Top-down MS, a powerful complement to the high capabilities of proteolysis proteomics. FEBS J. 2007, 274, 6256-6268.
45. Berggren, K., Chernokalskaya, E., Steinberg, T.H., Kemper, C. et al., Background-free, high sensitivity staining of proteins in one- and two-dimensional sodium dodecyl sulfate-polyacrylamide gels using a luminescent ruthenium complex. Electrophoresis 2000, 21, 2509-2521.
46. Tonge, R., Shaw, J., Middleton, B., Rowlinson, R. et al., Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 2001, 1, 377-396.
47. Siuti, N., Kelleher, N.L., Decoding protein modifications using top-down mass spectrometry. Nature Meth. 2007, 4, 817-821.
48. Motoyama, A., Yates, J.R., III, Multidimensional LC separations in shotgun proteomics. Anal. Chem. 2008, 80, 7187-7193.
49. Link, A.J., Eng, J., Schieltz, D.M., Carmack, E. et al., Direct analysis of protein complexes using mass spectrometry. Nat. Biotechnol. 1999, 17, 676-682.
50. Washburn, M.P., Wolters, D., Yates, J.R., III, Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 2001, 19, 242-247.
51. Wolters, D.A., Washburn, M.P., Yates, J.R., III, An automated multidimensional protein identification technology for shotgun proteomics. Anal. Chem. 2001, 73, 5683-5690.
52. 18O into peptide fragments and its application for protein sequencing by electrospray and matrix-assisted laser desorption/ionization mass spectrometry. Electrophoresis 1996, 17, 945-953.
53. Ong, S.E., Blagoev, B., Kratchmarova, I., Kristensen, D.B. et al., Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1, 376-386.
54. Cordwell, S.J., Len, A.C., Touma, R.G., Scott, N.E. et al., Identification of membrane-associated proteins from Campylobacter jejuni strains using complementary proteomics technologies. Proteomics 2008, 8, 122-139.
55. Macek, B., Mijakovic, I., Olsen, J.V., Gnad, F. et al., The serine/threonine/tyrosine phosphoproteome of the model bacterium Bacillus subtilis. Mol. Cell. Proteomics 2007, 6, 697-707.
56. Guerry, P., Szymanski, C.M., Campylobacter sugars sticking out. Trends Microbiol. 2008, 16, 428-435.
57. Hunter, T., Signaling - 2000 and beyond. Cell 2000, 100, 113-127.
58. Gooderham, W.J., Hancock, R.E., Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa. FEMS Microbiol. Rev. 2009, 33, 279-294.
59. Hecker, M., Pané-Farré, J., Völker, U., Sig-B dependent general stress response in Bacillus subtilis and related gram-positive bacteria. Ann. Rev. Microbiol. 2007, 61, 215-236.
60. Puls, J., Fischer, W., Haas, R., Activation of Helicobacter pylori CagA by tyrosine phosphorylation is essential for dephosphorylation of host cell proteins in gastric epithelial cells. Mol. Microbiol. 2002, 43, 961-969.
61. Selbach, M., Paul, F.E., Brandt, S., Guye, P. et al., Host cell interactome of tyrosine-phosphorylated bacterial proteins. Cell Host Microbe 2009, 5, 397-403.
62. Macek, B., Gnad, F., Soufi, B., Kumar, C. et al., Phosphoproteome analysis of E coli reveals evolutionary conservation of bacterial Ser/Thr/Tyr phosphorylation. Mol. Cell. Proteomics 2008, 7, 299-307.
63. Ravichandran, A., Sugiyama, N., Tomita, M., Swarup, S., Ishihama, Y., Ser/Thr/Tyr phosphoproteome analysis of pathogenic and non-pathogenic Pseudomonas species. Proteomics 2009, 9, 2764-2775.
64. Hitchen, P.G., Dell, A., Bacterial glycoproteomics. Microbiology 2006, 152, 1575-1580.
65. Karlyshev, A.V., Ketley, J.M., Wren, B.W., The Campylobacter jejuni glycome. FEMS Microbiol. Rev. 2005, 29, 377-390.
66. Szymanski, C.M., Wren, B.W., Protein glycosylation in bacterial mucosal pathogens. Nat. Rev. Microbiol. 2005, 3, 225-237.
67. Verma, A., Schirm, M., Arora, S.K., Thibault, P. et al., Glycosylation of b-type flagellin of Pseudomonas aeruginosa: structural and genetic basis. J. Bacteriol. 2006, 188, 4395-4403.
68. Castric, P., Cassels, F.J., Carlson, R.W., Structural characterization of the Pseudomonas aeruginosa 1244 pilin glycan. J. Biol. Chem. 2001, 276, 26479-26485.
69. Smedley, J.G., III, Jewell, E., Roguskie, J., Horzempa, J. et al., Influence of pilin glycosylation on Pseudomonas aeruginosa 1244 pilus function. Infect. Immun. 2005, 73, 7922-7931.
70. Wiehlmann, L., Munder, A., Adams, T., Juhas, M. et al., Functional genomics of Pseudomonas aeruginosa to identify habitat-specific determinants of pathogenicity. Int. J. Med. Microbiol. 2007, 297, 615-623.
71. Llamas, M.A., Sparrius, M., Kloet, R., Jimenez, C.R. et al., The heterologous siderophores ferrioxamine B and ferrichrome activate signaling pathways in Pseudomonas aeruginosa. J. Bacteriol. 2006, 188, 1882-1891.
72. Van Delden, C., Iglewski, B.H., Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg. Infect. Dis. 1998, 4, 551-560.
73. Heijerman, H., Infection and inflammation in cystic fibrosis: a short review. J. Cyst. Fibros. 2005, 4, 3-5.
74. Rommens, J.M., Iannuzzi, M.C., Kerem, B., Drumm, M.L. et al., Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989, 245, 1059-1065.
75. Al-Aloul, M., Crawley, J., Winstanley, C., Hart, C.A. et al., Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients. Thorax 2004, 59, 334-336.
76. Römling, U., Fiedler, B., Bosshammer, J., Grothues, D. et al., Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J. Infect. Dis. 1994, 170, 1616-1621.
77. Römling, U., Kader, A., Sriramulu, D.D., Simm, R., Kronvall, G., Worldwide distribution of Pseudomonas aeruginosa clone C strains in the aquatic environment and cystic fibrosis patients. Environ. Microbiol. 2005, 7, 1029-1038.
78. Jones, A.M., Govan, J.R., Doherty, C.J., Dodd, M.E. et al., Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak. Thorax 2003, 58, 525-527.
79. Guilbault, C., Saeed, Z., Downey, G.P., Radzioch, D., Cystic fibrosis mouse models. Am. J. Respir. Cell. Mol. Biol. 2007, 36, 1-7.
80. Davis, P.B., Cystic fibrosis since 1938. Am. J. Respir. Crit. Care Med. 2006, 173, 475-482.
81. Steyn, B., Oosthuizen, M.C., MacDonald, R., Theron, J., Brozel, V.S., The use of glass wool as an attachment surface for studying phenotypic changes in Pseudomonas aeruginosa biofilms by two-dimensional gel electrophoresis. Proteomics 2001, 1, 871-879.
82. Mikkelsen, H., Duck, Z., Lilley, K.S., Welch, M., Interrelationships between colonies, biofilms, and planktonic cells of Pseudomonas aeruginosa. J. Bacteriol. 2007, 189, 2411-2416.
83. Manos, J., Arthur, J., Rose, B., Tingpej, P. et al., Transcriptome analyses and biofilm-forming characteristics of a clonal Pseudomonas aeruginosa from the cystic fibrosis lung. J. Med. Microbiol. 2008, 57, 1454-1465.
84. Landry, R.M., An, D., Hupp, J.T., Singh, P.K., Parsek, M.R., Mucin-Pseudomonas aeruginosa interactions promote biofilm formation and antibiotic resistance. Mol. Microbiol. 2006, 59, 142-151.
85. Sauer, K., Camper, A.K., Ehrlich, G.D., Costerton, J.W., Davies, D.G., Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J. Bacteriol. 2002, 184, 1140-1154.
86. Vilain, S., Cosette, P., Hubert, M., Lange, C. et al., Proteomic analysis of agar gel-entrapped Pseudomonas aeruginosa. Proteomics 2004, 4, 1996-2004.
87. Sriramulu, D.D., Lunsdorf, H., Lam, J.S., Römling, U., Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung. J. Med. Microbiol. 2005, 54, 667-676.
88. Cordwell, S.J., Nouwens, A.S., Walsh, B.J., Comparative proteomics of bacterial pathogens. Proteomics 2001, 1, 461-472.
89. Fux, C.A., Shirtliff, M., Stoodley, P., Costerton, J.W., Can laboratory reference strains mirror "real-world" pathogenesis? Trends Microbiol. 2005, 13, 58-63.
90. Carrillo, C.D., Taboada, E., Nash, J.H., Lanthier, P. et al., Genome-wide expression analyses of Campylobacter jejuni NCTC11168 reveals coordinate regulation of motility and virulence by flhA. J. Biol. Chem. 2004, 279, 20327-20338.
91. Mathee, K., Narasimhan, G., Valdes, C., Qiu, X. et al., Dynamics of Pseudomonas aeruginosa genome evolution. Proc. Natl. Acad. Sci. USA 2008, 105, 3100-3105.
92. Scott, N.E., Cordwell, S.J., Campylobacter proteomics: guidelines, challenges and future perspectives. Exp. Rev. Proteomics 2009, 6, 61-74.
93. Sarkisova, S., Patrauchan, M.A., Berglund, D., Nivens, D.E., Franklin, M.J., Calcium-induced virulence factors associated with the extracellular matrix of mucoid Pseudomonas aeruginosa biofilms. J. Bacteriol. 2005, 187, 4327-4337.
94. Patrauchan, M.A., Sarkisova, S.A., Franklin, M.J., Strainspecific proteome responses of Pseudomonas aeruginosa to biofilm-associated growth and to calcium. Microbiology 2007, 153, 3838-3851.
95. Hajjar, A.M., Ernst, R.K., Tsai, J.H., Wilson, C.B., Miller, S.I., Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat. Immunol. 2002, 3, 354-359.
96. Ernst, R.K., Yi, E.C., Guo, L., Lim, K.B. et al., Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 1999, 286, 1561-1565.
97. Guina, T., Purvine, S.O., Yi, E.C., Eng, J. et al., Quantitative proteomic analysis indicates increased synthesis of a quinolone by Pseudomonas aeruginosa isolates from cystic fibrosis airways. Proc. Natl. Acad. Sci. USA 2003, 100, 2771-2776.
98. Guina, T., Wu, M., Miller, S.I., Purvine, S.O. et al., Proteomic analysis of Pseudomonas aeruginosa grown under magnesium limitation. J. Am. Soc. Mass Spectrom. 2003, 14, 742-751.
99. Stutts, M.J., Canessa, C.M., Olsen, J.C., Hamrick, M. et al., CFTR as a cAMP-dependent regulator of sodium channels. Science 1995, 269, 847-850.
100. Denning, G.M., Railsback, M.A., Rasmussen, G.T., Cox, C.D., Britigan, B.E., Pseudomonas pyocyanine alters calcium signaling in human airway epithelial cells. Am. J. Physiol. 1998, 274, L893-L900.
101. Chang, W., Small, D.A., Toghrol, F., Bentley, W.E., Microarray analysis of Pseudomonas aeruginosa reveals induction of pyocin genes in response to hydrogen peroxide. Biomed. Chromatogr. Genomics 2005, 6, 115.
102. Salunkhe, P., von Götz, F., Wiehlmann, L., Lauber, J. et al., GeneChip expression analysis of the response of Pseudomonas aeruginosa to paraquat-induced superoxide stress. Genome Lett. 2002, 1, 165-174.
103. Salunkhe, P., Topfer, T., Buer, J., Tümmler, B., Genomewide transcriptional profiling of the steady-state response of Pseudomonas aeruginosa to hydrogen peroxide. J. Bacteriol. 2005, 187, 2565-2572.
104. Schwarzer, C., Fischer, H., Kim, E.J., Barber, K.J. et al., Oxidative stress caused by pyocyanin impairs CFTR Cl(-) transport in human bronchial epithelial cells. Free Radic. Biol. Med. 2008, 45, 1653-1662.
105. Vinckx, T., Matthijs, S., Cornelis, P., Loss of the oxidative stress regulator OxyR in Pseudomonas aeruginosa PAO1 impairs growth under iron-limited conditions. FEMS Microbiol. Lett. 2008, 288, 258-265.
106. Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U. et al., Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 2002, 109, 317-325.
107. Yoon, S.S., Hennigan, R.F., Hilliard, G.M., Ochsner, U.A. et al., Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev. Cell 2002, 3, 593-603.
108. Wu, M., Guina, T., Brittnacher, M., Nguyen, H. et al., The Pseudomonas aeruginosa proteome during anaerobic growth. J. Bacteriol. 2005, 187, 8185-8190.
109. Platt, M.D., Schurr, M.J., Sauer, K., Vazquez, G. et al., Proteomic, microarray, and signature-tagged mutagenesis analyses of anaerobic Pseudomonas aeruginosa at pH 6.5, likely representing chronic, late-stage cystic fibrosis airway conditions. J. Bacteriol. 2008, 190, 2739-2758.
110. Coleman, F.T., Mueschenborn, S., Meluleni, G., Ray, C. et al., Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection. Proc. Natl. Acad. Sci. USA 2003, 100, 1949-1954.
111. Oliver, A., Canton, R., Campo, P., Baquero, F., Blazquez, J., High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 2000, 288, 1251-1254.
112. Hogardt, M., Hoboth, C., Schmoldt, S., Henke, C. et al., Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis. J. Infect. Dis. 2007, 195, 70-80.
113. Montanari, S., Oliver, A., Salerno, P., Mena, A. et al., Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosis. Microbiology 2007, 153, 1445-1454.
114. Beckmann, C., Brittnacher, M., Ernst, R., Mayer-Hamblett, N. et al., Use of phage display to identify potential Pseudomonas aeruginosa gene products relevant to early cystic fibrosis airway infections. Infect. Immun. 2005, 73, 444-452.
115. Rao, A.R., Laxova, A., Farrell, P.M., Barbieri, J.T., Proteomic identification of OprL as a seromarker for the initial diagnosis of Pseudomonas aeruginosa infection of patients with cystic fibrosis. J. Clin. Microbiol. 2009, 47, 2483-2488.
116. Pedersen, S.K., Sloane, A.J., Prasad, S.S., Sebastian, L.T. et al., An immunoproteomic approach for identification of clinical biomarkers for monitoring disease: application to cystic fibrosis. Mol. Cell. Proteomics 2005, 4, 1052-1060.
117. Pier, G., Application of vaccine technology to prevention of Pseudomonas aeruginosa infections. Exp. Rev. Vaccines 2005, 4, 645-656.
118. Weimer, E.T., Lu, H., Kock, N.D., Wozniak, D.J., Mizel, S.B., A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa. Infect. Immun. 2009, 77, 2356-2366.
119. Mansouri, E., Blome-Eberwein, S., Gabelsberger, J., Germann, G., von Specht, B.U., Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF-OprI vaccine in burn patients. FEMS Immunol. Med. Microbiol. 2003, 37, 161-166.
120. Thomas, L.D., Cripps, A.W., Kyd, J.M., Immune response mechanisms against Pseudomonas aeruginosa associated with mucosal immunization with protein antigens in a rat model of acute lung infection. Vaccine 2009, 27, 3324-3330.
121. Tashiro, Y., Nomura, N., Nakao, R., Senpuku, H. et al., Opr86 is essential for viability and is a potential candidate for a protective antigen against biofilm formation by Pseudomonas aeruginosa. J. Bacteriol. 2008, 190, 3969-3978.
122. Pier, G.B., Promises and pitfalls of Pseudomonas aeruginosa lipopolysaccharide as a vaccine antigen. Carbohydr. Res. 2003, 338, 2549-2556.
123. Hassett, D.J., Sutton, M.D., Schurr, M.J., Herr, A.B. et al., Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways. Trends Microbiol. 2009, 17, 130-138.
124. Parsek, M.R., Tolker-Nielsen, T., Pattern formation in Pseudomonas aeruginosa biofilms. Curr. Opin. Microbiol. 2008, 11, 560-566.
125. Wagner, V.E., Iglewski, B.H., P aeruginosa biofilms in CF Infection. Clin. Rev. Allergy Immunol. 2008, 35, 124-134.
126. Bajmoczi, M., Gadjeva, M., Alper, S.L., Pier, G., Golan, D.E., Cystic fibrosis transmembrane conductance regulator and caveolin-1 regulate epithelial cell internalization of Pseudomonas aeruginosa. Am. J. Physiol. Cell Physiol. 2009, 297, C263-C277.
127. MacEachran, D.P., Ye, S., Bomberger, J.M., Hogan, D.A. et al., The Pseudomonas aeruginosa secreted protein PA2934 decreases apical membrane expression of the cystic fibrosis transmembrane conductance regulator. Infect. Immun. 2007, 75, 3902-3912.
128. Painter, R.G., Bonvillain, R.W., Valentine, V.G., Lombard, G.A. et al., The role of chloride anion and CFTR in killing of Pseudomonas aeruginosa by normal and CF neutrophils. J. Leukoc. Biol. 2008, 83, 1345-1353.
129. Moreau-Marquis, S., Bomberger, J.M., Anderson, G.G., Swiatecka-Urban, A. et al., The DeltaF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability. Am. J. Physiol. Lung Cell Mol. Physiol. 2008, 295, L25-L37.
130. Yu, H., Zeidan, Y.H., Wu, B.X., Jenkins, R.W. et al., Defective acid sphingomyelinase pathway with Pseudomonas aeruginosa infection in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 2009, 41, 367-375.
131. Schuster, M., Lostroh, C.P., Ogi, T., Greenberg, E.P., Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: a transcriptome analysis. J. Bacteriol. 2003, 185, 2066-2079.
132. Hentzer, M., Wu, H., Andersen, J.B., Riedel, K. et al., Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J. 2003, 22, 3803-3815.
133. Wagner, V.E., Bushnell, D., Passador, L., Brooks, A.I., Iglewski, B.H., Microarray analysis of Pseudomonas aeruginosa quorum-sensing regulons: effects of growth phase and environment. J. Bacteriol. 2003, 185, 2080-2095.
134. Arevalo-Ferro, C., Hentzer, M., Reil, G., Görg, A. et al., Identification of quorum-sensing regulated proteins in the opportunistic pathogen Pseudomonas aeruginosa by proteomics. Environ. Microbiol. 2003, 5, 1350-1369.
135. Passador, L., Cook, J.M., Gambello, M.J., Rust, L., Iglewski, B.H., Expression of Pseudomonas aeruginosa virulence genes requires cell-to-cell communication. Science 1993, 260, 1127-1130.
136. Brint, J.M., Ohman, D.E., Synthesis of multiple exoproducts in Pseudomonas aeruginosa is under the control of RhlR-RhlI, another set of regulators in strain PAO1 with homology to the autoinducer-responsive LuxR-LuxI family. J. Bacteriol. 1995, 177, 7155-7163.
137. Latifi, A., Winson, M.K., Foglino, M., Bycroft, B.W. et al., Multiple homologues of LuxR and LuxI control expression of virulence determinants and secondary metabolites through quorum sensing in Pseudomonas aeruginosa PAO1. Mol. Microbiol. 1995, 17, 333-343.
138. Pearson, J.P., Pesci, E.C., Iglewski, B.H., Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes. J. Bacteriol. 1997, 179, 5756-5767.
139. Toder, D.S., Gambello, M.J., Iglewski, B.H., Pseudomonas aeruginosa LasA: a second elastase under the transcriptional control of lasR. Mol. Microbiol. 1991, 5, 2003-2010.
140. Gambello, M.J., Kaye, S., Iglewski, B.H., LasR of Pseudomonas aeruginosa is a transcriptional activator of the alkaline protease gene (apr) and an enhancer of exotoxin A expression. Infect. Immun. 1993, 61, 1180-1184.
141. Hassett, D.J., Ma, J.F., Elkins, J.G., McDermott, T.R. et al., Quorum sensing in Pseudomonas aeruginosa controls expression of catalase and superoxide dismutase genes and mediates biofilm susceptibility to hydrogen peroxide. Mol. Microbiol. 1999, 34, 1082-1093.
142. Ochsner, U.A., Reiser, J., Autoinducer-mediated regulation of rhamnolipid biosurfactant synthesis in Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 1995, 92, 6424-6428.
143. Pesci, E.C., Milbank, J.B., Pearson, J.P., McKnight, S. et al., Quinolone signaling in the cell-to-cell communication system of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 1999, 96, 11229-11234.
144. Deziel, E., Lepine, F., Milot, S., He, J. et al., Analysis of Pseudomonas aeruginosa 4-hydroxy-2-alkylquinolines (HAQs) reveals a role for 4-hydroxy-2-heptylquinoline in cell-to-cell communication. Proc. Natl. Acad. Sci. USA 2004, 101, 1339-1344.
145. Nouwens, A.S., Beatson, S.A., Whitchurch, C.B., Walsh, B.J. et al., Proteome analysis of extracellular proteins regulated by the las and rhl quorum sensing systems in Pseudomonas aeruginosa PAO1. Microbiol. 2003, 149, 1311-1322.
146. Chapon-Herve, V., Akrim, M., Latifi, A., Williams, P. et al., Regulation of the xcp secretion pathway by multiple quorum-sensing modulons in Pseudomonas aeruginosa. Mol. Microbiol. 1997, 24, 1169-1178.
147. El Solh, A.A., Alhajhusain, A., Update on the treatment of Pseudomonas aeruginosa pneumonia. J. Antimicrob. Chemother. 2009, 64, 229-238.
148. Mesaros, N., Nordmann, P., Plesiat, P., Roussel-Delvallez, M. et al., Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clin. Microbiol. Infect. 2007, 13, 560-578.
149. Zhou, J., Hao, D., Wang, X., Liu, T. et al., An important role of a "probable ATP-binding component of ABC transporter" during the process of Pseudomonas aeruginosa resistance to fluoroquinolone. Proteomics 2006, 6, 2495-2503.
150. Bjarnsholt, T., Jensen, P.O., Burmolle, M., Hentzer, M. et al., Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. Microbiology 2005, 151, 373-383.
151. Hirakata, Y., Kaku, M., Mizukane, R., Ishida, K. et al., Potential effects of erythromycin on host defense systems and virulence of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 1992, 36, 1922-1927.
152. Nalca, Y., Jansch, L., Bredenbruch, F., Geffers, R. et al., Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach. Antimicrob. Agents Chemother. 2006, 50, 1680-1688.
153. Chemani, C., Imberty, A., de Bentzmann, S., Pierre, M. et al., Role of LecA and LecB lectins in Pseudomonas aeruginosa-induced lung injury and effect of carbohydrate ligands. Infect. Immun. 2009, 77, 2065-2075.
154. Bauman, S.J., Kuehn, M.J., Pseudomonas aeruginosa vesicles associate with and are internalized by human lung epithelial cells. Biomed Chromatogr. Microbiol. 2009, 9, 26.